跳至主要内容
临床试验/NCT05410028
NCT05410028招募中不适用

New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence Via Analysis of Immunoinflammation-related Protein Complexes in Blood

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2022年3月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Immune Inflammation-Related Protein Complexes

研究概览

简要总结

In this study, mass spectrometry was used to analyze immune inflammation-related protein complexes, post-translational modified glycopeptide omics and tumor-related metabolomics in serum, respectively, in order to find potential metabolic small molecule biomarkers or marker profiles that can be used for early diagnosis of cancer recurrence.

详细描述

Time cohort study: patients with confirmed ovarian epithelial cancer at different time cutoff points before treatment, after surgery, during chemotherapy, and after chemotherapy, until clinically confirmed patients relapse. At least 50 patients are expected to be enrolled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A diagnosed patient with epithelial ovarian cancer

排除标准

  • Suffering from other malignant tumors
  • Non-compliant patient
  • Age above 70

结局指标

主要结局

Immune Inflammation-Related Protein Complexes

时间窗: 2 years

The change of immune inflammation-related protein complexes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

New Serum Biomarkers for Monitoring Early Diagnosis... | 临床试验